A new coronavirus test can detect past and present COVID-19 infections in just 20 minutes. The Independent reported that blood samples were used by Australian researchers in their newly developed COVID-19 test to determine novel coronavirus infections in 20 minutes; they claimed that is is a world-first breakthrough.
The World Economic Forum named the Crispr-based COVID-19 test as a Technology Pioneer. After partnering with Binx health on July 1, Sherlock Biosciences announced that it would scale up the rapid diagnostic test for a point-of-care setting so that the innovation could be used not only in doctors' offices, but also in grocery stores, supermarket, and other workplaces.
The report explained that the scientists and researchers of Sherlock Biosciences based their technology on the bacterial immune system, which can edit genes. Crispr typically uses a piece of guide RNA to act just like a "wanted poster" to look for a target gene of interest. After it locates the gene, its enzymatic partner, the Cas9 "molecular scissors," will snip it off.
